Make Confident, Successful

Healthcare Technology Investments

Private equity and venture capital investors looking to buy or exit healthcare technology companies trust KMS Healthcare to guide smart decisions and elevate company performance

Talk with Us

Why Investors Partner with KMS Healthcare

Diligence and value-building for healthcare software companies require special experience and knowledge. KMS Healthcare uniquely understands and helps investors assess the considerations for healthcare technology:

Necessary but complex interoperability

To be market viable, healthcare software must flawlessly consume and exchange data with EMR systems. That means effectively applying FHIR, SMART on FHIR, and other emerging acronyms and promising technologies.

Health apps and the Internet of Medical Things

Keeping patient information safe is paramount. We’re always up-to-date with HIPAA rules and cybersecurity practices to protect sensitive health info. Ensuring data security isn’t just about following the law; it’s about respecting patients and providers, enhancing credibility and value in the market.

Navigating Healthcare Regulations

Healthcare technology is shaped by many laws and standards, from the HITECH Act to the 21st Century Cures Act. We stay informed so we can help develop software that’s not only innovative but also fully compliant.

Empowering Healthcare Through Technology

The future of healthcare is about convenience and connection. We specialize in building apps and technology that put better care right in the palm of your hand—whether through a smartwatch, a phone, or other home devices—and can help both build and assess the viability of these apps.

KMS Healthcare understands all of these needs and nuances of healthcare software compliance and development.

Be assured your investments are smart and secure.

And investors trust KMS Healthcare’s remarkable track record of developing, launching, and successfully exiting our own software companies. Build strong relationships, make winning technology decisions, and invest with confident strategy.

Do Superior Due Diligence

Our healthcare technology due diligence uncovers the true risks and challenges of your investment strategy. We’ll identify your best opportunities so you can make stronger purchasing decisions that increase your rate of return.

Develop Applications that Change the Market

Our senior-level teams have peerless experience deploying top-tier healthcare software products. We help companies automate and turn AI and the cloud into business success. We test early in the development cycle and accelerate delivery with confidence.

Create Exceptional Value and Quality

We’ve built, operated, and sold industry-leading software companies. Our specialized approach to healthcare software development allows us to build powerful products that add value to your portfolio of companies.

Exit Victoriously

We have supported more than $11B in successful company exits, maximizing business value and getting to market fast. KMS executes and develops with a sharply formed sharp strategy to pave the way for the wildly successful exit for your software companies.

Get the Diligence You’re Due
with KMS Healthcare

Discover

We work with you to gain clarity on your needs, defining clear healthcare technology business outcomes to set up a successful engagement.

Elaborate

We determine the best solution for your needs and develop a plan of action for healthcare technology design, staffing, and delivery.

Build

Our superstar healthcare software engineers efficiently execute the plan and validate the solution, providing iterative delivery and constant communication.

Operate

We advance the business success of the final product, defining metrics, measuring desired results, and making the improvements that matter most for healthcare technology.

Outpace the Market with KMS

Get Started

KMS Powers Success for Healthcare Technology Investors

Driven in client acquisition value

$ 0 B

of KMS clients have been acquired

0 %

Software companies served & 50+ diligence projects

0 +

invested by PE firms in KMS clients